Customer Event Almaty
21 September 2023
Agenda
- 08:30–09:00 - Sign in and welcome
- 09:00–09:30 Keynote
- Dr. Venkat Surendra Nath Koduru, Senior Vice President, Regions & Program Operations
- Dr. Alessandro Slama, General Manager, USP EMEA
- Dr. Yerken Dautbaev, General Director - Chair of the Board of National Center for Drug Expertise
- 09:30–10:50 Session 1 - Pharmacopeia quality standards (Moderated by: Dr. Zakiya Al-Kurdi)
- 09:30–10:00: General Overview of USP: Key Activities and Role in Assuring the Quality of Medicines (Stefano D’Amico, USP Strategic Customer Development Manager EMEA)
- 10:00–10:20: The State Pharmacopoeia Kazakhstan as a fundamental document on the quality of medicines (Ardak Tulegenova, Head of the Department of the SPh, National Center for Medicines and Medical Devices MoH of Kazakhstan)
- 10:20–10:50: The value of USP Reference standards (online)
(Dr. Christian Zeine, USP Senior Scientific Affairs Manager EMEA)
- 10:50–11:10 Coffee Break
- 11:10–12:30 Session 2 - Drug manufacturing major aspects (Moderated by: Dr. Marina Durmanova)
- 11:10–11:30: Contracting manufacturing development in Kazakhstan: opportunities and barriers (Marina Durmanova, President, Pharma Industry Support and Development Association, Kazakhstan)
- 11:30–11:50: Challenges of international pharmaceutical manufacturers in Kazakhstan (Svetlana Ospanova, Executive Director, Association of International Pharmaceutical Manufacturers in Kazakhstan)
- 11:50–12:10: Development of pharmaceutical clusters in Uzbekistan
(Ulugbek Elgamov, Director, Pharmaceutical Industry Development Agency, Uzbekistan) - 12:10–12:30: Validation, Transfer and Verification of analytical procedures
(Amanda Guiraldelli, USP Scientific Affairs Manager EMEA)
- 12:30–13:30 Lunch
- 13:30–15:50 Session 3 - Drug quality major aspects (Moderated by: Dr. Bayan Moldakhmetova)
- 13:30–14:00: Challenges during impurity testing and Pharmaceutical Analytical Impurities (Christian Zeine, USP Senior Scientific Affairs Manager EMEA)
- 14:00–14:30: Nitrosamines Impurities (Amanda Guiraldelli, USP Scientific Affairs Manager EMEA)
- 14:30–14:50: Control of visible particulate matter during the production of parenteral medicinal products (Bereke Tanaguzova, Quality Director & QP in Karaganda Pharmaceutical Complex)
- 14:50–15:10: The experience of Kazakhstan in the development and production of the COVID-19 vaccine «QazVac» (Yergali Abduraimov, General Director, QazBioPharm | Lespek Kutumbetov, Chief Scientist, Biological safety Scientific Research Institute by the MoH of the RoK)
- 15:10–15:30: USP and Vaccine Quality: Standards to support public health and safety (online) (John Cipollo, Team Lead, Senior Principal Scientist Global Biologics)
- 15:30–16:00: Open discussion: How to organize an effective training on drug quality issues? (Moderated by: Alessandro Slama, Stefano D’Amico)
The agenda is subject to change. If there are any changes, we will announce them via email.
Agenda in Kazakh (қазақ тілі)
Agenda in Russian (русский язык)
Venue
The forum will be held at the DoubleTree:
115 Dosmukhamedov Street
Almaty 0500-00, Kazakhstan
Phone: +7 727 320 4200